219 related articles for article (PubMed ID: 31263674)
21. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
McCawley N; Clancy C; O'Neill BD; Deasy J; McNamara DA; Burke JP
Dis Colon Rectum; 2016 Dec; 59(12):1200-1208. PubMed ID: 27824706
[TBL] [Abstract][Full Text] [Related]
22. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
23. Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Lutsyk M; Awawda M; Gourevich K; Ben Yosef R
Am J Clin Oncol; 2021 Sep; 44(9):482-486. PubMed ID: 34269693
[TBL] [Abstract][Full Text] [Related]
24. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
25. Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Zeng WG; Liang JW; Wang Z; Zhang XM; Hu JJ; Hou HR; Zhou HT; Zhou ZX
Chin J Cancer; 2015 Aug; 34(10):468-74. PubMed ID: 26268466
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
[TBL] [Abstract][Full Text] [Related]
27. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
28. Identification of proteins associated with treatment response of neoadjuvant chemoradiotherapy in rectal mucinous adenocarcinoma by co-expression network analysis based on proteomic analysis.
Sun Y; Lin Y; Deng Y; Wu X; Zhong J; Huang Y; Jiang W; Chi P
J Proteomics; 2022 Mar; 254():104472. PubMed ID: 34990823
[TBL] [Abstract][Full Text] [Related]
29. [The value of MR T2WI signal intensity related parameters for predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer].
Wan LJ; Zhang CD; Zhang HM; Meng YK; Ye F; Liu Y; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):837-843. PubMed ID: 31770851
[No Abstract] [Full Text] [Related]
30. Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Li C; Guan Z; Zhao Y; Sun T; Li Z; Wang W; Li Z; Wang L; Wu A
Chin J Cancer Res; 2022 Aug; 34(4):383-394. PubMed ID: 36199540
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment identification of patients likely to have pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer.
van der Sluis FJ; van Westreenen HL; van Etten B; van Leeuwen BL; de Bock GH
Int J Colorectal Dis; 2018 Feb; 33(2):149-157. PubMed ID: 29247263
[TBL] [Abstract][Full Text] [Related]
32. [Predictive factors of pathological complete response after neoadjuvant chemoradiotherapy for middle-low rectal cancer].
Liu QZ; Zhang H; Hao LQ; Lou Z; Liu LJ; Gao XH; Gong HF; Hong YG; Xin C; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1159-1163. PubMed ID: 33353270
[No Abstract] [Full Text] [Related]
33. A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.
Lin Y
BMC Surg; 2022 Jul; 22(1):256. PubMed ID: 35787802
[TBL] [Abstract][Full Text] [Related]
34. Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.
Borggreve AS; Heethuis SE; Boekhoff MR; Goense L; van Rossum PSN; Brosens LAA; van Lier ALHMW; van Hillegersberg R; Lagendijk JJW; Mook S; Ruurda JP; Meijer GJ
Eur Radiol; 2020 Apr; 30(4):1896-1907. PubMed ID: 31822974
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors of complete pathological response in patients with locally advanced rectal cancer.
Engel RM; Oliva K; Koulis C; Yap R; McMurrick PJ
Int J Colorectal Dis; 2020 Sep; 35(9):1759-1767. PubMed ID: 32474708
[TBL] [Abstract][Full Text] [Related]
36. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
37. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
38. A nomogram predicting pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: implications for organ preservation strategies.
Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X
Oncotarget; 2017 Sep; 8(40):67732-67743. PubMed ID: 28978067
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Recurrence of Radically Resected Mucinous Colorectal Adenocarcinoma.
Huang Q; Zou MH; Wei JC; Jiang Y; Chen ZP; Wang Q; Li WL; Cao J
Cancer Manag Res; 2021; 13():4777-4790. PubMed ID: 34168497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
